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Purpose: This study was conducted to evaluate the surgical outcomes of active in-
fective endocarditis with aortic root abscess formation. Materials and Methods: 
Between February 1999 and June 2012, 49 patients underwent surgery for active 
endocarditis with aortic root abscess. The infected valve was native in 29 patients 
and prosthetic in 20 patients. The patients’ mean age was 50±14 years, and 36 pa-
tients were male. Surgery was urgent/emergent in 15 patients (31%). The abscess 
involved the aortic annulus (11), left ventricular outflow tract (18), fibrous trigone 
(16), and mitral annulus (4). In all patients, wide debridement of abscess and aortic 
valve replacement  with or without patch reconstruction of aortic root or annulus 
was performed. Results: There were 6 (12%) operative deaths. Causes of early 
mortality were sepsis (2) and multi-organ failure (4). On postoperative echocardio-
gram, there was significant improvement of left ventricular dimension (LVEDD, 
from 58.8±11.8 mm to 52.6±8.2 mm, p<0.001); however, LV ejection fraction was 
significantly decreased (from 61.4±12.0% to 49.8±16.5%, p<0.001). The mean 
follow-up duration was 68.7±40.4 months. There was no late death or recurrent 
endocarditis during follow up. New York Heart Association functional class signifi-
cantly improved from 3.2±0.7 to 1.2±0.4 (p<0.001). Kaplan-Meier estimated sur-
vival at 10 years was 87.2%. Conclusion: Surgical treatment for active endocardi-
tis with aortic root abscess is still challenging, and was associated with high 
operative mortality. Nevertheless, long-term survival was excellent with good 
functional capacity after recovery from the early postoperative period.
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INTRODUCTION
Although advances in antimicrobial therapies have been achieved, approximately 
one-third of patients with active infective endocarditis require surgery to save the pa-
tient’s life and eradicate the infection, for which the overall outcomes remain poor.1-4 
Endocarditis affecting the aortic valve combined with abscess formation is particular-
ly challenging to treat, and requires aggressive diagnostic and therapeutic approaches 
because of severe complications associated therewith, such as heart block, destruction 
of intervalvular fibrosa involving the mitral valve, fistula to other cardiac chambers, 
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eration of the retrospective nature of the study. 
The infected valves were native in 29 patients and pros-
thetic in 20 patients. The patients’ mean age was 50±14 
years, and 36 patients were male. Surgery was performed in 
urgent or emergent cases in 15 patients (31%). The main in-
dications for surgery included progressive heart failure caus-
ing hemodynamic instability in 41 patients (84%), large veg-
etation with recurrent septic embolism in 6 patients (12%), 
and early prosthetic infection (<60 days) in 2 patients (4%). 
Twenty-five patients (51%) had preoperative systemic em-
bolic event, and 8 patients (16%) were in shock. Seven pa-
tients (14%) required renal replacement therapy for preopera-
tive acute renal failure. Patient characteristics and preopera-
tive echocardiographic data are described in Table 1.
Transthoracic echocardiography and transesophageal 
echocardiography were performed in all patients preopera-
tively, and coronary angiography was performed in 29 pa-
tients (59%), including 3 patients who exhibited regional 
wall motion abnormality on an echocardiogram or had a 
previous history of coronary artery disease. Aortic root ab-
scess was diagnosed by preoperative transthoracic or trans-
esophageal echocardiography in 43 patients (88%), and 
was detected during operation in the others.
Microorganisms were identified in 33 patients (67.3%) 
aortic pseudoaneurysm formation, and extrinsic compression 
of coronary arteries.5-8 
Due to the aggressiveness of this disease and a wide 
spectrum of clinical presentations, according to the various 
complications, no randomized prospective study has been 
conducted thereon, and there are only a few retrospective 
studies. Therefore, we aimed to review our data to analyze 
10-year clinical outcomes in patients who underwent sur-
gery to treat active infective endocarditis combined with 
aortic root abscess.
MATERIALS AND METHODS
　　　
A total of 220 patients were surgically treated for infective 
endocarditis between February 1999 and June 2012 at Sev-
erance Cardiovascular Center, Yonsei University College of 
Medicine. Among these patients, data from 49 patients who 
underwent surgery for active endocarditis combined with 
aortic root abscess were retrospectively reviewed. Data were 
extracted from the hospital’s computerized database, with 
additional information obtained through retrospective re-
cord review. The Institutional Review Board approved the 
study and waived the need for informed consent in consid-
Table 1. Patient Characteristics
Total (n=49) Native valve (n=29) Prosthetic valve (n=20) p value
Mean age (yrs)   50.2±14.1   49.8±18.6   51.2±12.6 0.778
Male gender (%) 36 (73.5) 21 (72.4) 15 (75) 0.840
Electrocardiogram (%)
    NSR 39 (79.6) 25 (86.2) 14 (70.0) 0.282
    A-fib 4 (8.2) 1 (3.4)   3 (15.0) 0.104
    Heart block   6 (12.2)   3 (10.3)   3 (15.0) 0.386
Embolic event (%) 26 (53.1) 15 (51.7) 11 (55.0) 0.821
Cardiogenic/septic shock (%)   8 (16.3)   4 (13.8)   4 (20.0) 0.563
Renal failure (%)   7 (14.3)   4 (13.8)   3 (15.0) 0.762
Urgent/emergent operation (%) 15 (30.6)   9 (31.0)   6 (30.0) 0.449
Echocardiogram
    AR grade   2.8±1.3   2.7±1.3   2.8±1.5 0.807
    MR grade   1.5±1.2   1.5±1.4   1.3±1.1 0.572
    LVESD (mm) 40.8±8.9 40.1±9.5 41.7±8.3 0.564
    LVEDD (mm)   59.0±11.4   57.8±12.3   60.8±10.1 0.398
    LVEF (%)   61.8±11.9   62.3±12.3   61.2±11.7 0.766
    RVP (mm Hg)   40.8±11.8   41.4±12.1   40.1±11.7 0.741
NYHA Fc   3.2±0.7   3.3±0.8   3.1±0.8 0.245
Positive culture study (%) 33 (67.3) 20 (60.6) 13 (65.0) 0.771
NSR, normal sinus rhythm; A-fib, atrial fibrillation; AR, aortic regurgitation; MR, mitral regurgitation; LVESD, left ventricular end systolic dimension; LVEDD, 
left ventricular end diastolic dimension; LVEF, left ventricular ejection fraction; RVP, right ventricular pressure; NYHA Fc, New York Heart Association func-
tional class.
Data are presented as mean±SD. 
Surgical Experience with Aortic Root Abscess
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1255
made through the reconstructed neo-annulus. Aortic valve 
replacement was performed with mechanical valves in 38 
patients (78%), tissue valves in 7 patients (14%), and ho-
mografts in 3 patients (6%).
Patient clinical characteristics, echocardiographic param-
eters, and surgical data were obtained from review of medi-
cal records, and follow up was performed via reviewing 
hospital charts or conducting telephone interviews. One pa-
tient was lost to follow up; complete follow up was achieved 
in 97.6% (42/43) of all patients who survived.
All data are expressed as mean±standard deviation, fre-
quency, or a percentage. Continuous variables were com-
pared using the t-test, and categorical variables were com-
pared using the χ2 or Fisher exact test. Survival was evaluated 
with the Kaplan-Meier method, and the log-rank test was 
used to compare the groups. All statistical analyses were 
performed using Statistical Package for the Social Sciences 
preoperatively. Streptococcal species were the most com-
mon organisms in both types of prostheses (Table 2).
The abscess mainly involved the aortic annulus in 11 pa-
tients, left ventricular outflow tract in 18 patients, fibrous 
trigone in 16 patients, and mitral annulus in 4 patients. Five 
patients were complicated with formation of aortic false an-
eurysm, and 3 patients had fistula in the right atrium (1) or 
left atrium (2). In all patients, wide debridement of abscess 
and aortic valve repair or replacement with or without patch 
reconstruction of aortic root or annulus was performed (Ta-
ble 3). The infected native or prosthetic valves were re-
moved, and the abscess was radically excised along the 
edematous and potentially infected surrounding tissues. 
Special care was taken to minimize contamination of the 
operation field by changing surgical instruments and gloves 
after excision of all infected tissues. If a decision to recon-
struct the aortic root was made, autologous pericardium 
was harvested and pretreated in 1.5% glutaraldehyde solu-
tion for 3 minutes, followed by further rinsing in normal sa-
line for 3 minutes. All destructed tissues seen were excised, 
and pericardial patches were made 10--20% larger than the 
defect of the aortic root to be closed in order to minimize 
the chance of being detached due to tension. In cases of 
pericardial adhesion, bovine pericardium was used for re-
construction. In patients with extensive destruction of the 
annulus, a circumferential reconstruction of the annulus 
was performed, and the sutures for valve replacement were 
Table 2. Preoperatively Identified Microorganisms
Native valve 
(n=29)
Prosthetic 
valve (n=20)
Streptococcus viridans   2 (7%) 1 (5%)
Other streptococci 11 (38%) 7 (35%)
Staphylococcus aureus   2 (7%) 2 (10%)
Staphylococcus epidermidis   0 (0%) 2 (10%)
Enterococcus   2 (7%) 1 (5%)
Gram negative bacilli   3 (10%) 0 (0%)
Fungus   1 (3%) 0 (0%)
Table 3. Operative Procedure
Native (n=29) Prosthetic (n=20) Total (n=49)
Main location of abscess
    Aortic annulus   8   3 11 (22%)
    LVOT 13   5 18 (37%)
    Fibrous trigone   6 10 16 (33%)
    Mitral annulus   2   2   4 (8%)
Patch material for root reconstruction
    Autologous pericardium 18   0 18 (37%)
    Bovine pericardium   4 24 28 (57%)
    Dacron graft   2   1   3 (6%)
AV surgery
    AVR 25 16 41 (84%)
    AVP   1   0   1 (2%)
    Bentall   3   4   7 (14%)
Concomitant procedure
    CABG   2   0   2 (4%) 
    MV surgery 10   9 19 (39%)
    TV surgery   3   0   3 (6%)
    Aorta surgery   3   0   3 (6%)
AV, aortic valve; AVR, aortic valve replacement; AVP, aortic valvuloplasty; CABG, coronary artery bypass grafting; MV, mitral valve; TV, tricuspid valve; LVOT, 
left ventricular outflow tract.
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Echocardiographic data showed a significant decrease in 
left ventricular ejection fraction (61.4±12.0% to 49.8±16.5%, 
p<0.001). However, there were significant improvements in 
left ventricular end diastolic dimension (58.8±11.8 mm to 
52.6±8.2 mm, p<0.001), left atrial volume index (42.1±7.3 
mL/m2 to 39.4±6.5 mL/m2, p=0.008), and right ventricular 
pressure (43.3±10.8 mm Hg to 31.1±9.8 mm Hg, p<0.001). 
New York Heart Association functional class was also sig-
nificantly improved (mean 3.2±0.7 to 1.2±0.4, p<0.001) 
(Table 5).
Overall hospital mortality was 12.2% (6/49), and the 
causes of death included multi-organ failure in 4 patients 
and sepsis in 2 patients. Hospital mortality was higher for 
prosthetic valve endocarditis without statistical significance 
(Table 4). 
The mean follow up duration was 68.7±40.4 months 
(range: 2--159 months), and there was no late death or re-
currence of infective endocarditis during the follow up. 
One patient required reoperation for degeneration of bio-
prosthetic valve 4 years after the initial operation.
statistical software package, version 17.0 (SPSS Inc., Chi-
cago, IL, USA).
RESULTS
 
Patient characteristics for those with native valve endocar-
ditis or prosthetic valve endocarditis were not statistically 
different (Table 1). Operation time, aortic cross clamp time, 
cardiopulmonary bypass time, intensive care unit stay, and 
hospital stay were also not different between the two groups 
(Table 4). Postoperative complications included stroke in 
one patient, low cardiac output in 9 patients, renal failure 
requiring dialysis in 3 patients, re-exploration for bleeding 
in 2 patients, pacemaker implantation in 1 patient, percuta-
neous cardiopulmonary support (PCPS) in 2 patients, and 
tracheostomy in 1 patient. Two patients who required PCPS 
eventually died. There was no significant difference in de-
velopment of complications between the two valve types 
(Table 4). 
Table 4. Intraoperative and Postoperative Data
Native valve (n=29) Prosthetic valve (n=20) p value
Operation time (min)   350.3±110.7   360.1±152.7 0.798
ACC time (min) 151.1±42.9 177.4±85.9 0.169
CPB time (min) 194.2±47.6   231.4±117.3 0.135
Mechanical ventilation time (hrs)   17.2±19.1   25.1±57.8 0.497
ICU stay (days)   6.3±8.5   4.0±2.9 0.247
Hospital stay (days)   32.9±24.5   36.7±29.1 0.223
Postop. NYHA Fc (%)
    I 20 (74) 13 (81) 0.976
    II   7 (26)   3 (19) 0.485
    III   0 (0)   0 (0)
    IV   0 (0)   0 (0)
Complications (%)
    Stroke   1 (3)   0 (0)
    Low cardiac output   5 (17)   4 (20)
    Renal failure requiring dialysis   1 (3)   2 (10)
    Mediastinal bleeding   1 (3)   1 (5)
    Pacemaker insertion   1 (3)   0 (0)
    PCPS   0 (0)   2 (10)
    Tracheostomy   1 (3)   0 (0)
Hospital Mortality (%)   2 (6.9)   4 (13.8) 0.401
    Multi-organ failure   1   3
    Sepsis   1   1
Late mortality (%)   0 (0)   0 (0)
Recurrence of infective endocarditis (%)   0 (0)   0 (0)
Reoperation (%)   1 (4)   0 (0)
ACC, aortic cross clamp; CPB, cardiopulmonary bypass; ICU, intensive care unit; Postop., postoperative; NYHA Fc, New York Heart Association functional 
class; PCPS, percutaneous cardiopulmonary support.
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high.1-3 In contrast to infective endocarditis without root ab-
scess, urgent surgical treatment to eradicate the infected tis-
sue is mandatory to successfully treat patients with root ab-
scess. Also, delay in surgical treatment often results in 
periannular complications such as fistula to other cardiac 
chambers, false aneurysms, heart block, destruction of in-
tervalvular fibrous bodies, and involvement of mitral valve.4-8 
Therefore, once an aortic root abscess is detected, urgent 
surgery is required, as antibiotics alone will fail to control 
the infection and delay in surgical treatment may cause fa-
tal complications; such cases usually require a more com-
plex operation. However, the results of surgical treatment in 
these patients are still unsatisfactory, with high early mor-
Overall Kaplan-Meier estimated survival rates at 1, 5, 
and 10 years were 87.2%, 87.2%, and 87.2% (Fig. 1). Ka-
plan-Meier estimated survival rate at 10 years was higher in 
native valve endocarditis than prosthetic valve endocarditis 
(92.9% vs. 78.9%, p=0.165) without statistical significance 
(Fig. 2).
DISCUSSION
Despite major advances in antimicrobial therapies, diagnos-
tic technology, and surgical techniques, the mortality and 
morbidity of patients with infective endocarditis remain 
Table 5. Echocardiographic and Hemodynamic Data
Preop. Postop. p value
AR grade   2.8±1.3
MR grade   1.5±1.2
LVEF (%)   61.4±12.0   49.8±16.5 <0.001
LVEDD (mm)   58.8±11.8 52.6±8.2 <0.001
LVESD (mm) 40.9±8.9   39.7±10.0 0.226
LAVI (mL/m2) 42.1±7.3 39.4±6.5 0.008
RVP (mm Hg)   43.3±10.8 31.1±9.8 <0.001
s PAP (mm Hg)   38.6±13.5 32.1±7.1 0.049
d PAP (mm Hg) 21.3±8.5 17.8±7.9 0.124
m PAP (mm Hg)   37.0±21.2 23.1±6.2 0.012
CVP (mm Hg)   14.3±12.4 13.1±5.2 0.476
NYHA Fc   3.2±0.7   1.2±0.4 <0.001
Preop., preoperative; Postop., postoperative; AR, aortic regurgitation; MR, mitral regurgitation; LVEF, left ventricular ejection fraction; LVEDD, left ventricu-
lar end diastolic dimension; LVESD, left ventricular end systolic dimension; LAVI, left atrial volume index; RVP, right ventricular pressure; s PAP, systolic 
pulmonary artery pressure; d PAP, diastolic pulmonary artery pressure; m PAP, mean pulmonary artery pressure; CVP, central venous pressure; NYHA Fc, 
New York Heart Association functional class.
Fig. 1. Overall Kaplan-Meier estimated survival rates at 1, 5, and 10 years 
were 87.2%, 87.2%, and 87.2%. YSR, year survival rate.
Fig. 2. Kaplan-Meier estimated survival rate at 10 year was higher in native 
valve endocarditis than prosthetic valve endocarditis (92.9% vs. 78.9%, 
p=0.165) without statistical significance. YSR, year survival rate.
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Lastly, we only reviewed the patients who successfully un-
derwent surgical treatment, and patients who refused opera-
tion due to multiple strokes or intracranial hemorrhages with 
comatose mental status or patients who died before opera-
tion due to unstable hemodynamics or delayed diagnosis 
were not included. Therefore, the mortality of the disease 
might have been underestimated.   
The risk of early postoperative infection for mechanical 
and bioprosthetic valves is higher than that for homo-
grafts.17-19 In this study, mechanical valves were the most 
commonly used prosthesis, because a large portion of pa-
tients were young in age, homografts were not available in 
emergent situations, and the costs of homografts were too 
expensive; homografts were not covered by national insur-
ance until the year 2011 in our country. However, the rate 
of recurrent infection was 0% in all patients, and a recent 
study established by Musci, et al.19 suggested that even 
though the results of homograft aortic root replacement is 
satisfactory with low recurrence rate, the risk of structural 
valve deterioration increases over time, especially in young 
patients, and reoperation remains a challenge. Therefore, 
mechanical valves seem to be a good substitute, even in ac-
tive endocarditis with root abscess, if complete debride-
ment of infected tissue can be achieved.
The main limitation of this study was the small sample size 
and its retrospective nature.  However, due to the aggressive-
ness of this disease and the wide spectrum of clinical presen-
tations, according to the various complications, no random-
ized prospective study can be easily performed. Nevertheless, 
our study may provide some information to clinicians who 
find it difficult to treat this aggressive disease.
In conclusion, surgical treatment for active endocarditis 
with aortic root abscess is still challenging, and was associ-
ated with high operative mortality. However, long-term sur-
vival was excellent, with good functional capacity after re-
covery from the early postoperative period. Preoperative 
accurate diagnosis, aggressive follow up for proper opera-
tive timing, and appropriate surgical strategy might im-
prove early and long-term outcome in these patients.
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